0J1R.L
HCA Healthcare, Inc.
LSEUSDEQUITY
DELAYED
Last price
434.30
▲ 27.86 (6.85%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
406.44
Day high
434.30
Day low
431.74
Volume
1
Market cap
—
P/E (TTM)
0.20
52W range
216.00 – 434.30
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on 0J1R.L open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
35.96M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 7, 26 | MARKS MIKE A Chief Financial Officer |
STOCK | 3.34K | $0 | Direct |
| Apr 28, 26 | SMITH ANDREA B Director |
STOCK | 509 | $0 | Direct |
| Apr 28, 26 | JOHNSTON HUGH F. Director |
STOCK | 809 | $0 | Direct |
| Apr 28, 26 | FRIST WILLIAM R. Director and Beneficial Owner of more than 10% of a Class of Security |
STOCK | 809 | $0 | Direct |
| Apr 28, 26 | MICHELSON MICHAEL W Director |
STOCK | 925 | $0 | Direct |
| Apr 28, 26 | FRIST THOMAS F III Director and Beneficial Owner of more than 10% of a Class of Security |
STOCK | 1.04K | $0 | Direct |
| Apr 28, 26 | CHIDSEY JOHN W Director |
STOCK | 809 | $0 | Direct |
| Apr 28, 26 | DEPARLE NANCY-ANN M. J.D. Director |
STOCK | 509 | $0 | Direct |
| Apr 28, 26 | RILEY WAYNE JOSEPH Director |
STOCK | 509 | $0 | Direct |
| Feb 18, 26 | MCALEVEY MICHAEL R. Officer |
SELL | 1.69K | $903.54K | Direct |
| Feb 13, 26 | MCALEVEY MICHAEL R. Officer |
CONVERSION | 5.00K | $1.18M | Direct |
| Feb 11, 26 | WYATT CHRISTOPHER F Officer |
SELL | 4.00K | $2.02M | Direct |
| Feb 11, 26 | BERRES JENNIFER Officer |
SELL | 8.02K | $4.13M | Direct |
| Feb 10, 26 | BERRES JENNIFER Officer |
STOCK | 7.12K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
AKDAMAR EROL R |
Officer | 127.34K | Sale |
BILLINGTON PHILLIP G |
Officer | 52.70K | Sale |
CUFFE MICHAEL S |
Officer | 32.08K | Stock Award(Grant) |
DENNIS ROBERT JAY |
Director | 26.60K | Stock Award(Grant) |
FOSTER JON MARK |
Chief Operating Officer | 194.52K | Stock Award(Grant) |
FRIST THOMAS F III |
Director and Beneficial Owner of more than 10% of a Class of Security | 68.86M | Stock Award(Grant) |
FRIST WILLIAM R. |
Director and Beneficial Owner of more than 10% of a Class of Security | 69.26M | Stock Award(Grant) |
HAZEN SAMUEL N |
Chief Executive Officer | 1.38M | Stock Award(Grant) |
MARKS MIKE A |
Chief Financial Officer | 73.08K | Stock Gift |
WYATT CHRISTOPHER F |
Officer | 44.38K | Sale |
Fundamentals
Market cap—
Enterprise value$146.82B
Revenue (TTM)$78.01B
Gross profit$33.22B
EBITDA$15.75B
Net income$6.84B
EPS (TTM)$21.29
Free cash flow$3.74B
Total cash$1.13B
Total debt$51.55B
Book value / share$-30.47
Shares outstanding344.16M
Float144.32M
Short % of float—
Dividend yield—
Beta (5Y)1.11
Valuation & profitability ratios
Trailing P/E0.20
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue1.88
EV / EBITDA9.32
Gross margin42.58%
Operating margin15.16%
Profit margin8.77%
Return on equity—
Return on assets12.29%
Debt / equity—
Current ratio0.99
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $19.37B | +1.1% |
| Next quarter | — | — | $19.85B | +1.7% |
| Current year | — | — | $78.51B | +3.9% |
| Next year | — | — | $81.62B | +4.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders16.61%
Held by institutions78.95%
Institutions holding1.86K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
1.11
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Aug 3, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 28, 26 | Goldman Sachs | MAINTAINED | Buy | Buy |
| Jul 28, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 27, 26 | UBS | MAINTAINED | Buy | Buy |
| Jul 27, 26 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
| Jul 27, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 27, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 27, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Jul 27, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Jul 27, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Jul 27, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
Headlines
Lumentum Holdings Insider Sold Shares Worth $2,055,477, According to a Recent SEC Filing
MT Newswires · 7m ago
Lumentum Holdings Insider Sold Shares Worth $1,576,169, According to a Recent SEC Filing
MT Newswires · 7m ago
ACADIA Pharmaceuticals Wins EU Approval for Rett Syndrome's Drug
MT Newswires · 8m ago
Stock market today: Dow, S&P 500, Nasdaq futures mixed after US-Canada talks break down
Yahoo Finance · 8m ago
Cerebras Systems Insider Sold Shares Worth $151,050,463, According to a Recent SEC Filing
MT Newswires · 8m ago
Global Emerging Robotics Market Outlook 2027-2037 by Vertical, Component, Business Model, Region and Units
GlobeNewswire · 8m ago
Here's what income is needed to live comfortably in Illinois
Journal Star · 9m ago
Global PFAS Industry Assessment 2027-2037: Regulatory Timelines, Technology Benchmarking and Forecasts
GlobeNewswire · 9m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.